Cigna (CI) EBITDA (2017 - 2026)

Cigna (CI) has 10 years of EBITDA data on file, last reported at $202.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 15.13% year-over-year to $202.0 million; the trailing twelve-month figure through Mar 2026 stood at $11.2 billion (up 1175.02% YoY), and the FY2025 full-year result was $9.2 billion, up 845.53% from the prior year.
• EBITDA retreated to $202.0 million in Q1 2026, from $8.5 billion in the prior quarter.
• In the past five years, EBITDA ranged from a high of $8.5 billion in Q4 2025 to a low of -$6.3 billion in Q4 2024.
• A 5-year average of $1.5 billion and a median of $325.0 million in 2022 frame the typical range for EBITDA.
• Across the five-year window, EBITDA surged 1875.53% in 2022 and tumbled 2262.41% in 2024, its largest moves.
• Tracing CI's EBITDA over 5 years: stood at $7.5 billion in 2022, then tumbled by 96.14% to $290.0 million in 2023, then plunged by 2262.41% to -$6.3 billion in 2024, then jumped by 235.43% to $8.5 billion in 2025, then plunged by 97.62% to $202.0 million in 2026.
• Business Quant data shows CI's EBITDA at $202.0 million in Q1 2026, $8.5 billion in Q4 2025, and $233.0 million in Q3 2025.